CYCLERION THERAPEUTICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
CYCLERION THERAPEUTICS, INC. (CYCN) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$3.53 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-07-22.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-07-22
- CYCLERION THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$5.18M.
- CYCLERION THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$44.06M.
- CYCLERION THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was -$51.69M.
- CYCLERION THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2020 was -$77.88M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$3.53M S-4/A · filed 2026-07-22 | |
| 2024-12-31 | -$3.06M S-4/A · filed 2026-07-22 | -$3.06M 10-K · filed 2025-03-04 |
| 2023-12-31 | -$5.18M 10-K/A · filed 2025-11-12 | |
| 2022-12-31 | -$44.06M 10-K · filed 2024-03-05 | |
| 2021-12-31 | -$51.69M 10-K · filed 2023-03-22 | |
| 2020-12-31 | -$77.88M 10-K · filed 2022-02-24 | |
| 2019-12-31 | -$122.44M 10-K · filed 2021-02-25 | |
| 2018-12-31 | -$115.25M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |